GSK capitalises on Covid-19 trend to save the NHS £2 billion
GlaxoSmithKline is on a mission to bring self-care into the mainstream in a bid to grow its consumer business and take the pressure off the National Health Service (NHS).
Craig Percival, Marketing Director of GSK Consumer Healthcare, said his team will capitalise on the Covid-19 fuelled trend for “self-care” in a bid to empower consumers, drive brand growth and divert pressure away from the NHS.
Percival assumed the role of marketing director for GSK Consumer Healthcare UK and Ireland in January this year, having previously served as oral health marketing director as part of a 14-year career at the pharma giant. His task is to unite the two product portfolios and develop a marketing culture that maximises the opportunities presented by the new business.
Last July the company formed pharmaceutical super-group GSK Consumer Healthcare, in a £10bn deal uniting GSK brands including Sensodyne, Voltaren and Panadol, with Pfizer brands such as Centrum and Caltrate.
GSK is now the global leader in over-the-counter pharmaceutical products, spanning pain relief, cold and flu symptoms, allergies, vitamins and minerals. The organisation has ambitious plans to reinvest 25% of the £500m savings generated through the joint venture into innovation and other “growth opportunities” over the next two years.
RECOMMENDED ARTICLES
Comment
No comments found.